Monsenso (MONSO.CO) Stock Analysis & AI Equity Report
Monsenso (MONSO.CO) overview
Monsenso (MONSO.CO) stock analysis and AI equity research. For the latest completed financial year, 2024, Monsenso reported revenue of DKK 11.2m and operating profit of DKK -6.5m; the year-end share price was N/A and market capitalisation was N/A. Monsenso is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Monsenso's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-18. Data will be refreshed during report generation.
About Monsenso
Monsenso A/S develops a digital health software platform for mental health care and research. Its cloud-based solution collects patient-reported and sensor data from smartphones and wearables, supports remote monitoring and treatment support, and gives clinicians a web portal for viewing patient information. The company also serves healthcare providers, researchers and pharmaceutical users.
Generate the Monsenso report
Monsenso is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Monsenso and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.